Lab
Apex Labs INC
Apex Labs INC was paid $123K by Medicaid between Feb 2022 and Dec 2022, across 6 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 63% of everything it billed.
33Billing provider infoAPEX LABS INC
NILES, IL 60714
NILES, IL 60714
33aNPI1649895871assigned 06/12/2020
33bProvider typeClinical Medical Laboratory
28Total paid$123K
24GClaims1,798
24DCodes billed6
24AFirst – last monthFeb 2022 – Dec 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Illinois
Rank by total paid#118 of 235
Median peer was paid$123K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 1,798 | $123K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 63% | 558 | 366 | $78K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 25% | 891 | 501 | $30K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 8.6% | 150 | 118 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.6% | 141 | 113 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 30 | 27 | $890.88 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 28 | 26 | $432.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAMAL, IBRAHIM (DIRECTOR)